ArcticZymes Technologies ASA (OSL: AZT)
18.98
-0.72 (-3.65%)
Aug 30, 2024, 4:25 PM CET
AZT Revenue
ArcticZymes Technologies ASA had revenue of 27.55M NOK in the quarter ending June 30, 2024, a decrease of -2.38%. This brings the company's revenue in the last twelve months to 117.80M, up 0.21% year-over-year. In the year 2023, ArcticZymes Technologies ASA had annual revenue of 119.65M, down -13.09%.
Revenue (ttm)
117.80M
Revenue Growth
+0.21%
P/S Ratio
8.36
Revenue / Employee
1.93M
Employees
61
Market Cap
969.33M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 119.65M | -18.02M | -13.09% |
Dec 31, 2022 | 137.67M | 6.62M | 5.05% |
Dec 31, 2021 | 131.05M | 33.23M | 33.96% |
Dec 31, 2020 | 97.82M | 48.65M | 98.92% |
Dec 31, 2019 | 49.18M | -23.64M | -32.46% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Medistim ASA | 533.17M |
Nordhealth AS | 471.77M |
Nykode Therapeutics AS | 69.44M |
Photocure ASA | 513.58M |
Carasent ASA | 254.01M |
Hofseth BioCare ASA | 230.08M |
Gentian Diagnostics ASA | 151.51M |
Navamedic ASA | 543.49M |